- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 09.09. | Lundbeck retreats from dozens of markets, slashing staff | ||
| 09.09. | Lilly offers AI discovery models to biotech partners | ||
| 09.09. | ICER says GLP-1s 'still have serious affordability issues' | ||
| 09.09. | Lilly eyes earlier use of blood cancer drug Jaypirca | ||
| 09.09. | NHS trust league tables arrive in UK health shakeup | ||
| 09.09. | US anti-vaccine rhetoric trumpeted in UK, thanks to Reform | ||
| 09.09. | After a long biotech IPO lull, LB Pharma chances its arm | ||
| 09.09. | Novartis nabs cardio drug with $1.4bn Tourmaline buy | ||
| 08.09. | Mixed data from lung cancer trials on show at WCLC | ||
| 08.09. | FDA lends a hand to Novo, Lilly on illegal GLP-1 imports | ||
| 08.09. | NRG raises £50m to start trials of Parkinson's, ALS drug | ||
| 08.09. | Servier bets $450m on Fragile X syndrome drug | ||
| 05.09. | Massachusetts bucks HHS, issuing its own COVID guidelines | ||
| 05.09. | Poll paints picture of menopause discrimination at work | ||
| 05.09. | FDA releases previously unseen CRLs in transparency push | ||
| 05.09. | Treeline's $200m Series A extension, and other biofinancings | ||
| 04.09. | RFK faces bipartisan pressure at fractious hearing | ||
| 04.09. | Remedy Meds buys telehealth rival in $500m marriage | ||
| 04.09. | Gilead, Amgen kick off facility investments in US | ||
| 04.09. | Sanofi slumps despite positive eczema drug readout | ||
| 04.09. | Ametris starts obesity digital endpoint project with pharma | ||
| 04.09. | Dismay as Florida seeks to end vaccination protections | ||
| 04.09. | Medical groups, federal staffers call for RFK Jr to resign | ||
| 03.09. | Novartis pens $5.2bn cardiovascular partnership with Argo | ||
| 03.09. | Eisai moves swiftly to expand subcutaneous Leqembi label |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .